An estimated seven to ten million people worldwide are living with Parkinson’s disease (PD), which is an incurable and progressive disease of the nervous system affecting movement and cognitive function. More than half of PD patients develop progressive disease showing signs of dementia similar to Alzheimer’s disease. A research team at University of Copenhagen, Denmark, has discovered that non-inheritable PD may be caused by functional changes in the immune regulating gene Interferon-beta (IFN?). Treatment with IFN?-gene therapy successfully prevented neuronal death and disease effects in an experimental model of PD. The results have just been published in prestigious scientific journal Cell.
Protein regulates waste management in nerve cells
The human brain consists of approximately 100 billion neurons, which coordinate activities in all parts of the body. At Biotech Research and Innovation Centre (BRIC), University of Copenhagen, the group of Professor Shohreh Issazadeh-Navikas has discovered that the immune gene IFN? plays a vital role in keeping neurons healthy.
-We found that IFN? is essential for neurons ability to recycle waste proteins. Without this, the waste proteins accumulate in disease-associated structures called Lewy bodies and with time the neurons die, explains assistant professor Patrick Ejlerskov, the first author of this report.
The research team found that mice missing IFN? developed Lewy bodies in parts of the brain, which control body movement and restoration of memory, and as a result they developed disease and clinical signs similar to patients with PD and dementia with Lewy bodies (DLB).
New understanding of non-familial Parkinson’s disease
While hereditary gene mutations have long been known to play a role in familial PD, the study from BRIC offers one of the first models for so-called non-familial PD, which comprises the majority (90-95%) of patients suffering from PD. According to professor Shohreh Issazadeh-Navikas the new knowledge opens new therapeutic possibilities:
–This is one of the first genes found to cause pathology and clinical features of non-familial PD and DLB, through accumulation of disease-causing proteins. It is independent of gene mutations known from familial PD and when we introduced IFN?-gene therapy, we could prevent neuronal death and disease development. Our hope is that this knowledge will enable development of more effective treatment of PD, says professor Shohreh Issazadeh-Navikas.
The Latest on: Parkinson’s
via Google News
The Latest on: Parkinson’s
- Lexington-based 'Space Tango' does out-of-this-world research on Parkinson's and MSon August 5, 2022 at 2:19 pm
"Sometimes you get a chance to do something fundamentally different from anything that's been done before and every time I get a chance like that I just say yes." ...
- Parkinson's research: Experimental nanobody targets toxic proteinson August 5, 2022 at 6:00 am
An experimental nanobody treatment that can untangle misshapen proteins in the brain may better address the symptoms of Parkinson's disease.
- Israeli study showing higher Parkinson’s disease risk in PTSD patients bolsters research on US veteranson August 4, 2022 at 2:04 pm
A new study published Thursday in the Journal of the American Medical Association concluded that there is a “robust” association between PTSD and Parkinson’s risk in men, particularly among elderly ...
- New longitudinal study links low religiosity to increased risk of Parkinson’s diseaseon August 4, 2022 at 10:00 am
According to a study published in the Journal of Religion and Health, low religiosity in adulthood is associated with an increased risk for developing Parkinson’s Disease (PD), among both England and ...
- Monoclonal Antibodies No Better Than Placebo for Early Parkinson Diseaseon August 4, 2022 at 9:02 am
The monoclonal antibodies cinpanemab and prasinezumab show almost no benefit for early Parkinson disease, according to two phase 2 trials published in the ...
- Two Strikes and Monoclonal Antibodies Are Out for Early Parkinson's?on August 3, 2022 at 2:33 pm
"The negative data have apparently not deterred the sponsor of PASADENA from commencing a phase 2b trial, although it does seem likely that the evidence in aggregate marks the end of the road for ...
- Meridian woman rides 8,000 miles for Parkinson’s Diseaseon August 3, 2022 at 7:48 am
Joni Pursell took her motorcycle across the country and back to honor those dealing with Parkinson’s disease. MERIDIAN, Idaho — Joni Pursell has been riding her motorcycle for many years now. She ...
- UA, Harvard researchers identify potential Parkinson's therapeuticon August 2, 2022 at 1:00 pm
Researchers at The University of Alabama were part of a national investigation that identified a new candidate therapeutic target for Parkinson’s Disease, according to recently published results. The ...
- What Is Parkinson’s Wellness Recovery, and How Can It Help With Parkinson’s Symptoms?on July 31, 2022 at 5:00 pm
Regular exercise is as important as medication for people with Parkinson’s disease, and Parkinson’s Wellness Recovery is all about helping them get the exercise they need.
- Protein Discovered in Parkinson’s Disease Could Lead to New Treatmentson July 26, 2022 at 3:39 pm
Research takes scientists closer to understanding α-synuclein (αSyn), which they find links inflammation and Parkinson’s disease.
via Bing News